Blindness News and Research

RSS

SENSIMED Triggerfish developed to diagnose and treat patients with glaucoma

STMicroelectronics, the world's leading supplier of MEMS (Micro-Electro-Mechanical Systems) devices for consumer and portable applications, has announced that it will develop and supply a wireless MEMS sensor that acts as a transducer, antenna and mechanical support for additional read-out electronics in a breakthrough platform developed by Swiss company Sensimed AG.

26 Mar 2010

New topical drug may help treat diabetic eye disease

Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.

26 Mar 2010

EVMS researchers awarded $1,076,250 grant to develop functional cure for Type 1 diabetes

Researchers at the Eastern Virginia Medical School Strelitz Diabetes Center have been awarded a $1,076,250 grant by the Department of Defense Peer Reviewed Medical Research Program to develop new ways of reversing the underlying causes of Type 1 diabetes.

26 Mar 2010

Isotechnika Pharma releases fourth quarter financial results; reviews operational and scientific highlights for 2009

Isotechnika Pharma Inc. has released its financial results for the fourth quarter and year ended December 31, 2009 and provided a review of the Company's operational and scientific highlights for 2009

25 Mar 2010

Bariatric surgery may delay onset of type 2 diabetes, says study

A team of researchers, led by a UC Davis veterinary endocrinologist, has shown for the first time that a surgical procedure in rats that is similar to bariatric surgery in humans can delay the onset of type 2 diabetes.

25 Mar 2010

Special medicated contact lenses can help treat common eye disorders

The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye - where it can treat that common disease- almost 100 times longer than possible with current commercial lenses, scientists reported here today.

25 Mar 2010

AHF to protest against Merck's pricing of Isentress

AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.

24 Mar 2010

High-density genotyping array launched to study complexity of mouse genetics

Affymetrix, Inc. and The Jackson Laboratory today announced the full commercial launch of the Affymetrix® Mouse Diversity Genotyping Array. This is the first high-density genotyping array that enables researchers to study the complexity of the mouse genome and the diversity among mouse strains.

24 Mar 2010

Researchers create audio CDs to encourage physical activity among school students

The National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University $1.22 million to combat childhood obesity in the Bronx.

24 Mar 2010

NPR's Car Talk guys team up with University of Utah to launch Driver Distraction Center

NPR's Car Talk guys, Tom and Ray Magliozzi, may be a couple of motor mouths, but they always put a lid on using cell phones behind the wheel. The perennial jokesters confirm their serious commitment to addressing the issue of devices that take a driver's focus off the road by teaming with the University of Utah to launch the Driver Distraction Center at their web site: cartalk.com/distraction.

23 Mar 2010

Diabetic Pennsylvanians can reduce risk of complications by following "ABCs" of diabetes

Secretary of Health Everette James reminds diabetic Pennsylvanians to reduce the risk of complications from the disease and improve their quality of life by knowing and following the "ABCs" of diabetes.

23 Mar 2010

JDRF, Pfizer, Hadassah Medical Organization, The Hebrew University of Jerusalem form diabetes research collaboration

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.

22 Mar 2010

Gene implicated in JSRDs: UCD research team publishes new information

Researchers in University College Dublin (UCD) led by Conway Fellow, Dr Oliver Blacque have revealed new information about a gene implicated in Joubert syndrome and related cerebellar disorders (JSRDs) that are characterised by blindness, bone abnormalities, cystic kidneys, developmental delay and loss of muscle tone and control. The findings from this research, which is funded by Science Foundation Ireland, have been published today in a leading science journal, Journal of Cell Biology.

22 Mar 2010

Nanotechnology weapons for cancer

US Researchers have come up with new nanoparticle robots that are essentially a tiny army that can travel in the blood till they reach the cancers and then tweak some important cancer causing genes that can cure the cancer.

22 Mar 2010

JDRF to begin diabetes research collaboration on drugs for replicating insulin-producing cells

22 Mar 2010

Prevent Blindness America, Real Kids Shades partner to promote children's eye protection

In an effort to educate parents about the need to protect children's eye health, Prevent Blindness America, the nation's leading volunteer eye health and safety organization, and Real Kids Shades a leading manufacturer of quality eyewear for infants and children, are teaming up to ensure that 5 million children have healthy eyes for healthy futures. The joint effort supports "Star Pupils," a national program of Prevent Blindness America designed to arm parents with the information they need to help their children achieve a lifetime of healthy vision.

19 Mar 2010

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Manitobans with wet age-related macular degeneration (AMD) received a dose of good news. The Manitoba government announced that Lucentis (ranibizumab injection) will soon be funded through a centralized vision program, effective June 1, 2010.

18 Mar 2010

Scientific revelations discovered during Retina Implant’s first human clinical trial

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company’s first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company’s expectations for their first trial.

18 Mar 2010

XOMA initiates Phase 2 clinical trial of XOMA 052 in Type 1 diabetes patients

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. Funding for the trial is being provided by the Juvenile Diabetes Research Foundation International, the largest patient advocacy organization of Type 1 diabetes research worldwide.

12 Mar 2010

Age-related macular degeneration affects central vision in older Americans

Indianapolis resident Harry Traugott was an active retiree, participating in community events, driving and even teaching English as a second language at two community centers. He’d been diagnosed with age-related macular degeneration (AMD), but the disease had not caused significant vision loss. It wasn’t until he had trouble seeing while driving, watching television

11 Mar 2010

Blindness News and Research

SENSIMED Triggerfish developed to diagnose and treat patients with glaucoma

New topical drug may help treat diabetic eye disease

EVMS researchers awarded $1,076,250 grant to develop functional cure for Type 1 diabetes

Isotechnika Pharma releases fourth quarter financial results; reviews operational and scientific highlights for 2009

Bariatric surgery may delay onset of type 2 diabetes, says study

Special medicated contact lenses can help treat common eye disorders

AHF to protest against Merck's pricing of Isentress

High-density genotyping array launched to study complexity of mouse genetics

Researchers create audio CDs to encourage physical activity among school students

NPR's Car Talk guys team up with University of Utah to launch Driver Distraction Center

Diabetic Pennsylvanians can reduce risk of complications by following "ABCs" of diabetes

JDRF, Pfizer, Hadassah Medical Organization, The Hebrew University of Jerusalem form diabetes research collaboration

Gene implicated in JSRDs: UCD research team publishes new information

Nanotechnology weapons for cancer

JDRF to begin diabetes research collaboration on drugs for replicating insulin-producing cells

Prevent Blindness America, Real Kids Shades partner to promote children's eye protection

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Scientific revelations discovered during Retina Implant’s first human clinical trial

XOMA initiates Phase 2 clinical trial of XOMA 052 in Type 1 diabetes patients

Age-related macular degeneration affects central vision in older Americans

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News